top
Search terms
Results 11 - 20 of 178 - ordered by :
Pages: 1 2 3 4 5 6 7 ... 18
Escardio

Shokoufeh GHEZELBASH for the presentation on ''Enhanced Expression and PKCdelta-mediated Hyperphosphorylation Underlie the Proarrythmic Increase in Sodium-Calcium-Exchanger Activity in Patients with ...

Date : 26/03/2018
Escardio

The clinical outcomes of noncompaction cardiomyopathy (NCCM) range from asymptomatic to heart failure, arrhythmias, and sudden cardiac death (Elliott 2008).. Genetics play an important role in NCCM ...

Date : 02/04/2018
Escardio

The suspicion of myocarditis was based on symptoms suggesting inflammatory heart disease (e.g. dyspnea, palpitations, chest pain, etc.), signs of recent or ongoing myocardial damage (wall motion ...

Date : 20/09/2017
Escardio

Results Median age was 41 years (interquartile range: 27 to 53 years) with similar prevalence in both sexes; pediatric cases accounted for 10.1%. Conclusion The authors conclude that EM has a poor ...

Date : 20/11/2017
Escardio

Hot Topics in 2018 Ankara - Spotlight Village Sunday 26 August 11:00-12:30 Tips, Tricks and Pearls in percutaneous coronary intervention Cairo - Spotlight Village Sunday 26 August 14:30-15:45 Meet ...

Date : 04/07/2018
Escardio

Hypertension also features as a session in the new Cardiology in 4 days series of lectures at the ESC, designed to provide comprehensive coverage of the entire field of cardiology in 4 days at the ...

Date : 17/07/2018
Escardio

Vice-Chairperson Jan Kovac, Lead for Specialised Cardiovascular Services, University Hospitals of Leicester NHS Trust, Professor of Interventional Cardiology University of Leicester, United Kingdom ...

Date : 19/06/2018
Escardio

The case EF 60% dyspnoea NYHA II and loss of performance male patient, age 61 weight: 99 kg; size: 182cm BMI: 29.89; Body surface: 2.20 m2 Test findings Spirometry ECG Derivation 9 Panel Plot of the ...

Date : 04/06/2018
Escardio

The continued scientific exchange and educational collaboration between cardiologists and strokologists is essential to further improve comprehensive patient care and to advance novel treatment ...

Date : 17/05/2018
Escardio

Within the DAPT trial, a high-risk score (i.e. a score ≥2) selected patients who showed a reduction in MI/stent thrombosis and cardiovascular or cerebrovascular events risk [ (NNT) for benefit for ...

Date : 30/04/2018